-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on MiMedx Group, Lowers Price Target to $6

Benzinga·04/30/2026 15:15:31
Listen to the news
Citizens analyst David Turkaly maintains MiMedx Group (NASDAQ:MDXG) with a Market Outperform and lowers the price target from $7 to $6.